Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1143

1.

A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.

Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.

Subst Use Misuse. 2006;41(9):1313-36.

PMID:
16861181
2.

HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico.

Deren S, Kang SY, Colón HM, Andia JF, Robles RR.

J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1067-74.

PMID:
15247560
3.

Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team.

Addiction. 2004 Sep;99(9):1136-46.

PMID:
15317634
4.

Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999.

Deren S, Robles R, Andia J, Colón HM, Kang SY, Perlis T.

J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):164-9.

PMID:
11242184
5.

Peer norms and sharing of injection paraphernalia among Puerto Rican injection drug users in New York and Puerto Rico.

Andía JF, Deren S, Robles RR, Kang SY, Colón HM.

AIDS Educ Prev. 2008 Jun;20(3):249-57. doi: 10.1521/aeap.2008.20.3.249.

PMID:
18558821
6.

Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico.

Robles RR, Colón HM, Matos TD, Finlinson HA, Muñoz A, Marrero CA, García M, Reyes JC.

Health Policy. 1998 Sep;45(3):209-20.

PMID:
10338952
7.

Predictors of injection drug use cessation among Puerto Rican drug injectors in New York and Puerto Rico.

Deren S, Kang SY, Colón HM, Robles RR.

Am J Drug Alcohol Abuse. 2007;33(2):291-9.

PMID:
17497552
8.

Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico.

Colón HM, Robles RR, Deren S, Sahai H, Finlinson HA, Andía J, Cruz MA, Kang SY, Oliver-Vélez D.

J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):405-13.

PMID:
11468430
9.

Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.

Bluthenthal RN, Kral AH, Erringer EA, Edlin BR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):505-11.

PMID:
9715848
10.

Continued risky injection subsequent to syringe exchange use among injection drug users in New York City.

Paone D, Des Jarlais DC, Caloir S, Jose B, Shi Q, Friedman SR.

AIDS Educ Prev. 1997 Dec;9(6):505-10.

PMID:
9451478
11.

Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.

Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.

PMID:
11404541
12.

The legality of selling or giving syringes to injection drug users.

Burris S, Vernick JS, Ditzler A, Strathdee S.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S13-8.

PMID:
12489604
13.

An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.

Lurie P, Gorsky R, Jones TS, Shomphe L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32.

PMID:
9663635
14.

Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?

Remis RS, Bruneau J, Hankins CA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S57-9.

PMID:
9663625
15.

Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.

Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.

PMID:
17286637
16.

Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S77-82.

PMID:
12489621
17.

Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.

Emmanuelli J, Desenclos JC.

Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.

PMID:
16277629
18.

New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.

MacGowan RJ, Sterk CE, Long A, Cheney R, Seeman M, Anderson JE.

Int J Epidemiol. 1998 Apr;27(2):302-8.

PMID:
9602414
19.

HIV transmission behaviors in jail/prison among puerto rican drug injectors in New York and Puerto Rico.

Kang SY, Deren S, Andia J, Colón HM, Robles R, Oliver-Velez D.

AIDS Behav. 2005 Sep;9(3):377-86.

PMID:
16133901
20.

Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto Rico.

Andía JF, Deren S, Kang SY, Robles RR, Colón HM, Oliver-Velez D, Finlinson A, Beardsley M, Friedman SR.

Am J Drug Alcohol Abuse. 2001 Nov;27(4):719-35.

PMID:
11727885

Supplemental Content

Support Center